Trial
NCT00118196
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Leukemia
Intervention
arsenic trioxide
Why stopped
Due to limited resources available to conduct study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-11